Literature DB >> 4431763

[Familial erythrocytosis among the residents of the Chuvash ASSR].

L A Poliakova.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4431763

Source DB:  PubMed          Journal:  Probl Gematol Pereliv Krovi        ISSN： 0552-2080


× No keyword cloud information.
  12 in total

1.  Iron deficiency modifies gene expression variation induced by augmented hypoxia sensing.

Authors:  Joe G N Garcia; Roberto F Machado; Victor R Gordeuk; Xu Zhang; Wei Zhang; Shwu-Fan Ma; Galina Miasniakova; Adelina Sergueeva; Tatiana Ammosova; Min Xu; Sergei Nekhai; Mehdi Nourai; Michael S Wade; Josef T Prchal
Journal:  Blood Cells Mol Dis       Date:  2013-08-28       Impact factor: 3.039

2.  Complications in children and adolescents with Chuvash polycythemia.

Authors:  Adelina I Sergueeva; Galina Y Miasnikova; Lydia A Polyakova; Mehdi Nouraie; Josef T Prchal; Victor R Gordeuk
Journal:  Blood       Date:  2015-01-08       Impact factor: 22.113

Review 3.  Hematopoietic growth factors, signaling and the chronic myeloproliferative disorders.

Authors:  Kenneth Kaushansky
Journal:  Cytokine Growth Factor Rev       Date:  2006-10-20       Impact factor: 7.638

4.  Increased size of solid organs in patients with Chuvash polycythemia and in mice with altered expression of HIF-1alpha and HIF-2alpha.

Authors:  Donghoon Yoon; David V Okhotin; Bumjun Kim; Yulia Okhotina; Daniel J Okhotin; Galina Y Miasnikova; Adelina I Sergueeva; Lydia A Polyakova; Alexei Maslow; Yonggu Lee; Gregg L Semenza; Josef T Prchal; Victor R Gordeuk
Journal:  J Mol Med (Berl)       Date:  2010-02-08       Impact factor: 4.599

5.  The heterozygote advantage of the Chuvash polycythemia VHLR200W mutation may be protection against anemia.

Authors:  Galina Y Miasnikova; Adelina I Sergueeva; Mehdi Nouraie; Xiaomei Niu; Daniel J Okhotin; Lydia A Polyakova; Tomas Ganz; Josef T Prchal; Victor R Gordeuk
Journal:  Haematologica       Date:  2011-05-23       Impact factor: 9.941

6.  Chuvash polycythemia VHLR200W mutation is associated with down-regulation of hepcidin expression.

Authors:  Victor R Gordeuk; Galina Y Miasnikova; Adelina I Sergueeva; Xiaomei Niu; Mehdi Nouraie; Daniel J Okhotin; Lydia A Polyakova; Tatiana Ammosova; Sergei Nekhai; Tomas Ganz; Josef T Prchal
Journal:  Blood       Date:  2011-08-29       Impact factor: 22.113

7.  Translational repression of HIF2α expression in mice with Chuvash polycythemia reverses polycythemia.

Authors:  Manik C Ghosh; De-Liang Zhang; Hayden Ollivierre; Michael A Eckhaus; Tracey A Rouault
Journal:  J Clin Invest       Date:  2018-02-26       Impact factor: 14.808

8.  Clinical Improvement with JAK2 Inhibition in Chuvash Polycythemia.

Authors:  Amy W Zhou; Eric M Knoche; Elizabeth K Engle; Makiko Ban-Hoefen; Charu Kaiwar; Stephen T Oh
Journal:  N Engl J Med       Date:  2016-08-04       Impact factor: 91.245

9.  Variations within oxygen-regulated gene expression in humans.

Authors:  Jerome T S Brooks; Gareth P Elvidge; Louisa Glenny; Jonathan M Gleadle; Chun Liu; Jiannis Ragoussis; Thomas G Smith; Nick P Talbot; Laura Winchester; Patrick H Maxwell; Peter A Robbins
Journal:  J Appl Physiol (1985)       Date:  2008-11-13

Review 10.  The human side of hypoxia-inducible factor.

Authors:  Thomas G Smith; Peter A Robbins; Peter J Ratcliffe
Journal:  Br J Haematol       Date:  2008-05       Impact factor: 6.998
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.